NICE director Dvir Yocheved discloses equity holdings

Q: What does the NICE (NCSYF) Form 3 for Dvir Yocheved disclose?

The Form 3 shows director Dvir Yocheved holding multiple stock options and 395 NICE ordinary shares. The options cover NICE ordinary shares at various exercise prices and expiration dates, providing a detailed view of her existing equity-based compensation and ownership in the company.

Q: What types of securities does Dvir Yocheved hold in NICE Ltd.?

Dvir Yocheved directly holds Ordinary Shares of NICE and several awards of Options over NICE ordinary shares. The options have distinct exercise prices and expiration dates, forming a portfolio of equity incentives aligned with NICE’s long-term performance.

Q: How many NICE ordinary shares does Dvir Yocheved own directly?

The filing reports direct ownership of 395 NICE ordinary shares. This is separate from the underlying shares associated with her stock option awards, which represent additional potential ownership if those options are exercised in the future.

Q: Does the NICE Form 3 show any recent insider buying or selling by Dvir Yocheved?

The data presented reflect holdings, not new purchases or sales, with transactions labeled as holdings and transaction codes described as unknown. It functions as an initial ownership snapshot rather than a record of recent buy or sell activity.

NICE Ltd. director Dvir Yocheved has reported current equity holdings in a Form 3 insider filing.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

NICE Ltd. director Dvir Yocheved has reported current equity holdings in a Form 3 insider filing. The disclosure lists multiple stock option awards over NICE ordinary shares with exercise prices ranging from 0.2929 to 232.2005 and expiration dates between 2026 and 2031. The filing also shows direct ownership of 395 NICE ordinary shares. Footnotes explain that some options are already fully vested and exercisable, while others will vest in installments through specific dates in 2026.

Insider Trade Summary

14 transactions reported

Mixed 14 txns

Insider Dvir Yocheved

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Options	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options — 22,895 contracts (Direct); Ordinary Shares — 395 shares (Direct)

Footnotes (3)

F1. The stock option is fully vested and currently exercisable.
F2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
F3. The stock option will vest on September 30, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the NICE (NCSYF) Form 3 for Dvir Yocheved disclose?

The Form 3 shows director Dvir Yocheved holding multiple stock options and 395 NICE ordinary shares. The options cover NICE ordinary shares at various exercise prices and expiration dates, providing a detailed view of her existing equity-based compensation and ownership in the company.

What types of securities does Dvir Yocheved hold in NICE Ltd.?

Dvir Yocheved directly holds Ordinary Shares of NICE and several awards of Options over NICE ordinary shares. The options have distinct exercise prices and expiration dates, forming a portfolio of equity incentives aligned with NICE’s long-term performance.

How many NICE ordinary shares does Dvir Yocheved own directly?

The filing reports direct ownership of 395 NICE ordinary shares. This is separate from the underlying shares associated with her stock option awards, which represent additional potential ownership if those options are exercised in the future.

What are key terms of Dvir Yocheved’s NICE stock options?

The options relate to NICE ordinary shares with exercise prices starting at 0.2929 and extending above 200, and expiration dates spanning from 2026 through 2031. These terms define when and at what price she may acquire NICE shares via the options.

What do the footnotes in Dvir Yocheved’s NICE Form 3 explain?

Footnotes clarify the vesting status of certain stock options. One footnote states an option is fully vested and currently exercisable, while others explain options that vest in installments or fully by specific dates in 2026, detailing when those options become exercisable.

Does the NICE Form 3 show any recent insider buying or selling by Dvir Yocheved?

The data presented reflect holdings, not new purchases or sales, with transactions labeled as holdings and transaction codes described as unknown. It functions as an initial ownership snapshot rather than a record of recent buy or sell activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/18/2026 - 09:23 AM EDT

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Dvir Yocheved

(Last)

(First)

(Middle)

221 RIVER STREET

(Street)

HOBOKEN

NEW JERSEY

07030

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NICE Ltd. [ NICE ]

3a. Foreign Trading Symbol
[NICE.TA]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	395	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	04/30/2026	Ordinary Shares	3,980	$151.63	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	2,785	$224.18	D
Options	⁽¹⁾	09/10/2026	Ordinary Shares	696	$0.2929	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	2,214	$232.2005	D
Options	⁽¹⁾	04/28/2027	Ordinary Shares	554	$0.3076	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	2,516	$197.4245	D
Options	⁽¹⁾	06/22/2028	Ordinary Shares	629	$0.2887	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	2,086	$206.5232	D
Options	⁽¹⁾	07/17/2029	Ordinary Shares	521	$0.2751	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	2,545	$168.4643	D
Options	⁽¹⁾	07/03/2030	Ordinary Shares	636	$0.2657	D
Options	⁽²⁾	09/30/2031	Ordinary Shares	2,987	$144.903	D
Options	⁽³⁾	09/30/2031	Ordinary Shares	746	$0.3025	D

Explanation of Responses:

1. The stock option is fully vested and currently exercisable.

2. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

3. The stock option will vest on September 30, 2026.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Alon Levy, Attorney-in-Fact for Yocheved Dvir	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR